跳至主要内容
临床试验/NCT01990287
NCT01990287终止不适用

SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation)Study for the Treatment of Chronic Low Back and Leg Pain

Abbott Medical Devices56 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
38
试验地点
56
主要终点
Safety

研究概览

简要总结

The purpose of the study is to demonstrate safety and efficacy of spinal cord stimulation with peripheral nerve field stimulation for the treatment of chronic low back and leg pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is 22 years of age or older
  • Subject has chronic low back and leg pain secondary to Failed Back Surgery Syndrome (FBSS)
  • Subject has an average score of 6 or higher for average daily overall pain on the Numerical Rating Scale (NRS) based on the 7 day pain diary
  • Subject has attempted "best" medical therapy and has tried and failed at least three documented medically supervised treatments (including, but not limited to physical therapy, acupuncture, etc.) and has failed medication treatment from at least two different classes
  • Subject's pain-related medication regimen is stable 4 weeks prior to the baseline evaluation
  • Subject agrees not to add or increase pain-related medication throughout the 12 week randomized evaluation phase of the study (starting at activation)

排除标准

  • Subject currently participating in a clinical investigation that includes an active treatment arm
  • Subject has been implanted with a previous neuromodulation system (PNfS, SCS-PNfS or SCS) or participated in a trial for a neuromodulation system
  • Subject's overall Beck Depression Inventory II Score is > 24 or has a score of 3 on question 9 relating to suicidal thoughts or wishes at the baseline visit
  • Subject with an infusion pump or any implantable neurostimulator device
  • Subject has an existing medical condition that is likely to require repetitive MRI evaluation in the future (i.e. epilepsy, stroke, multiple sclerosis, acoustic neuroma, tumor)
  • Subject has an existing medical condition that is likely to require the use of diathermy in the future
  • Subject has peripheral vascular disease
  • Subject is immunocompromised
  • Subject has documented history of allergic response to titanium or silicone
  • Subject has a documented history of substance abuse (narcotics, alcohol, etc.) or substance dependency in the 6 months prior to baseline data collection
  • Female candidates of child bearing potential that are pregnant (confirmed by positive pregnancy test)

结局指标

主要结局

Safety

时间窗: 6 months

Evaluation of device or procedure related adverse events

Efficacy

时间窗: 3 months

Responder rate in SCS-PNfS vs SCS alone

次要结局

  • Quality of Life(3 months)
  • Functional Disability(3 months)
  • Worst pain(3 months)
  • Rescue medication usage(3 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (56)

Loading locations...

相似试验